A Breath of Fresh Insight: Targeting CXCR4 in Early Chronic Obstructive Pulmonary Disease. [PDF]
Bignold RE, Johnson JR.
europepmc +1 more source
ABSTRACT Mesenchymal stromal cells (MSCs) exert their effects primarily through paracrine signaling via soluble factors and extracellular vesicles (EVs), especially exosomes. These acellular components offer regenerative and immunomodulatory benefits with fewer safety and logistical constraints than cell‐based therapies.
Marcela da Costa Pereira Cestari +2 more
wiley +1 more source
Integrated bioinformatics analysis to elucidate cellular communication in the microenvironment of breast cancer. [PDF]
Wang M +6 more
europepmc +1 more source
Emerging methods for subtype differentiation in primary aldosteronism
Abstract Primary aldosteronism (PA) is a common cause of hypertension. Compared to patients with essential hypertension, untreated PA is associated with a two‐ to fourfold greater risk of cardiovascular disease, renal failure, and death. PA is caused by increased secretion of aldosterone from one adrenal gland in 30% of the patients and both adrenal ...
Oskar Ragnarsson +5 more
wiley +1 more source
CCL26 and CXCL12 preserve insulin-sensitizing macrophages in subcutaneous adipose tissue in obesity. [PDF]
Jeelani I +12 more
europepmc +1 more source
Regulatory T cells in skin utilize the Cxcr4-Cxcl12 axis to promote hair follicle regeneration. [PDF]
Cohen JN +6 more
europepmc +1 more source
G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. [PDF]
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
europepmc +1 more source
Targeting the CXCR4/CXCL12 Axis to Overcome Drug Resistance in Triple-Negative Breast Cancer. [PDF]
Singh DD, Yadav DK, Shin D.
europepmc +1 more source
CXCR4 mediated recognition of HIV envelope spike and inhibition by CXCL12. [PDF]
Zhang Z +6 more
europepmc +1 more source
Platelets in the tumor microenvironment: potential mediators of immune exclusion and resistance to immune checkpoint inhibitor therapy. [PDF]
Nasir Kansestani A, Zare ME, Zhang J.
europepmc +1 more source

